Financial Statements — NSRX
Balance Sheet
(in millions USD)| Metric | Q2
2025 |
|---|
| Cash & Equivalents | 0.20 |
| Total Current Assets | 0.29 |
| Total Non-current Assets* | 0.35 |
| Total Assets | 0.64 |
| Accounts Payable | 0.66 |
| Total Current Liabilities | 4.95 |
| Total Non-current Liabilities* | 0.00 |
| Total Liabilities | 4.95 |
| Retained Earnings | (13.92) |
| Total Stockholder Equity | (4.31) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 |
|---|
| Research & Development | 0.29 |
| Selling, General & Admin | 0.53 |
| Total Operating Expenses | 0.82 |
| Operating Income | (0.82) |
| Net Income | (1.25) |
| Basic EPS | (0.17) |
| Diluted EPS | (0.17) |
Cash Flow Statement
(in thousands USD)| Metric | Q2
2025 |
|---|
| Operating Cash Flow | (433.00) |
| Financing Cash Flow | 360.00 |
